CD36 and metabolic dysfunction-associated steatotic liver disease: We have previously demonstrated that FA and HFD promote CD36 palmitoylation and distribution in the plasma membranes of hepatocytes, contributing to NAFLD development and progression (Zhao et al., 2018b).